These findings support the safety and feasibility of exercise for patients with hematological cancers, showing moderate improvements in physical function and HRQOL. However, heterogeneity in study designs and small sample sizes limit the generalizability of the results.
MORANTE-SAINZ et al. (2026) studied this question.